Global Mesalamine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The industry's leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively.
In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.

Market Analysis and Insights: Global Mesalamine Market
In 2020, the global Mesalamine market size was US$ 151.5 million and it is expected to reach US$ 189.1 million by the end of 2027, with a CAGR of 3.2% during 2021-2027.
Global Mesalamine Scope and Market Size
Mesalamine market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Mesalamine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Mesalamine market is segmented into
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%

Segment by Application, the Mesalamine market is segmented into
Mesalazine Tablets
Mesalazine Capsules
Others

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape

and Mesalamine Market Share Analysis
Mesalamine market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Mesalamine product introduction, recent developments, Mesalamine sales by region, type, application and by sales channel.

The major companies include:
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
Hangzhou Brother
PharmaZell
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical